TickerFactsScreenerDevelopers

ELITE PHARMACEUTICALS INC /NV/ (ELTP) — Operating Income

Annual figures by fiscal year, from SEC filings.

2011: -$885.8K2012: -$1.97M2013: -$1.56M2014: -$5.28M2015: -$16.51M2016: -$8.32M2017: -$7.36M2018: -$9.05M2019: -$9.16M2020: -$2.29M2021: $2.10M2022: $5.07M2023: $3.68M2024: $10.79M2025: $19.60M$19.60M
2011Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025$19.60M+81.7%
2024$10.79M+193.5%
2023$3.68M-27.5%
2022$5.07M+140.9%
2021$2.10M+192.1%
2020-$2.29M+75.0%
2019-$9.16M-1.2%
2018-$9.05M-23.0%
2017-$7.36M+11.6%
2016-$8.32M+49.6%
2015-$16.51M-212.4%
2014-$5.28M-238.0%
2013-$1.56M+20.5%
2012-$1.97M-122.0%
2011-$885.8K—